Virtu Financial LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 222 filers reported holding REATA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$682,000
+96.0%
20,815
+746.5%
0.05%
+47.1%
Q2 2021$348,000
-69.8%
2,459
-56.4%
0.03%
-69.6%
Q4 2019$1,152,000
+102.5%
5,634
-20.5%
0.11%
+154.5%
Q3 2019$569,000
+1.1%
7,085
+7.5%
0.04%
+37.5%
Q1 2019$563,0006,5910.03%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$94,902,00015.92%
Opaleye Management Inc. 407,002$13,333,0004.14%
Ikarian Capital, LLC 649,600$21,281,0002.80%
AWH Capital, L.P. 150,000$2,459,4572.54%
Boxer Capital, LLC 1,239,000$40,590,0002.09%
EcoR1 Capital, LLC 1,975,611$64,721,0002.02%
Camber Capital Management LP 1,500,000$49,140,0001.78%
MPM BioImpact LLC 180,000$5,897,0001.58%
Sofinnova Investments, Inc. 602,545$19,739,0001.50%
KRS Capital Management, LLC 28,141$921,0001.00%
View complete list of REATA PHARMACEUTICALS INC shareholders